Regentis Biomaterials Ltd. (AMEX:RGNT) IPO

Regentis Biomaterials Ltd.

IPO

Priced at US$8.00 a share on Dec 3, 2025.

Price
US$8.00 a share
Shares offered
1,250,000 ordinary shares
Offering size
US$10 million
Underwriters' option
Up to 187,500 more shares
Listing
RGNT on NYSE American
Underwriter
ThinkEquity
Shares delivered
On or about Dec 5, 2025

Steps

StepWhen
Draft sent to the SEC in confidenceNov 21, 2024
Filed publiclyMar 11, 2025
Amended 6 timesNewest Oct 24, 2025
Shares registered with an exchangeSep 9, 2025
Final prospectus, with the priceDec 4, 2025

Filings

FilingFiled
424B3 · ProspectusDec 4, 2025
CERT · Exchange's certificate of listingDec 3, 2025
FWP · Free writing prospectusOct 24, 2025
F-1/A · Registration statement, amendedOct 24, 2025
FWP · Free writing prospectusOct 6, 2025
F-1/A · Registration statement, amendedSep 30, 2025
CORRESP · Letter to the SECSep 17, 2025
CORRESP · Letter to the SECSep 17, 2025
CORRESP · Letter to the SECSep 15, 2025
CORRESP · Letter to the SECSep 15, 2025
CORRESP · Letter to the SECSep 10, 2025
8-A12B · Registration of shares for listing on an exchangeSep 9, 2025
F-1/A · Registration statement, amendedSep 9, 2025
CORRESP · Letter to the SECSep 8, 2025
CORRESP · Letter to the SECSep 8, 2025
FWP · Free writing prospectusJul 7, 2025
F-1/A · Registration statement, amendedJul 7, 2025
CORRESP · Letter to the SECMay 19, 2025
F-1/A · Registration statement, amendedMay 19, 2025
UPLOAD · Letter from the SECMay 13, 2025
CORRESP · Letter to the SECMay 5, 2025
F-1/A · Registration statement, amendedMay 5, 2025
UPLOAD · Letter from the SECMar 19, 2025
F-1 · Registration statementMar 11, 2025
CORRESP · Letter to the SECMar 10, 2025
UPLOAD · Letter from the SECFeb 19, 2025
DRS/A · Draft registration statement, amendedFeb 12, 2025
DRSLTR · Letter to the SEC with a draftFeb 11, 2025
UPLOAD · Letter from the SECFeb 5, 2025
DRS/A · Draft registration statement, amendedJan 27, 2025
DRSLTR · Letter to the SEC with a draftJan 24, 2025
DRS · Draft registration statementJan 24, 2025
UPLOAD · Letter from the SECDec 18, 2024
DRS · Draft registration statementNov 21, 2024

From the cover of the final prospectus (424B3) filed Dec 4, 2025